{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:53:12Z","timestamp":1791618792981,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,19]]},"DOI":"10.7759\/cureus.54483","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:11:25Z","timestamp":1708387885000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of Severe Proton Pump Inhibitor-Induced Hypomagnesemia Refractory to Continuous Oral and Intravenous Magnesium Replenishment"],"prefix":"10.7759","author":[{"given":"Karim","family":"Kheir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Al Jassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgio","family":"El Koubayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand DS","year":"2017","unstructured":"Strand DS, Kim D, Peura DA. 25 years of proton pump inhibitors: a comprehensive review. Gut Liver. 2017, 11:27-37. 10.5009\/gnl15502","journal-title":"Gut Liver"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-008-0098-4","article-title":"Pharmacology of proton pump inhibitors","volume":"10","author":"Shin JM","year":"2008","unstructured":"Shin JM, Sachs G. Pharmacology of proton pump inhibitors. Curr Gastroenterol Rep. 2008, 10:528-34. 10.1007\/s11894-008-0098-4","journal-title":"Curr Gastroenterol Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12759","article-title":"Adverse effects associated with proton pump inhibitor use","volume":"13","author":"Yibirin M","year":"2021","unstructured":"Yibirin M, De Oliveira D, Valera R, Plitt AE, Lutgen S. Adverse effects associated with proton pump inhibitor use. Cureus. 2021, 13:e12759. 10.7759\/cureus.12759","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017788","article-title":"Proton pump inhibitors and hypomagnesemia: a meta-analysis of observational studies","volume":"98","author":"Srinutta T","year":"2019","unstructured":"Srinutta T, Chewcharat A, Takkavatakarn K, Praditpornsilpa K, Eiam-Ong S, Jaber BL, Susantitaphong P. Proton pump inhibitors and hypomagnesemia: a meta-analysis of observational studies. Medicine (Baltimore). 2019, 98:e17788. 10.1097\/MD.0000000000017788","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9041694","article-title":"Magnesium and human health: perspectives and research directions","volume":"2018","author":"Al Alawi AM","year":"2018","unstructured":"Al Alawi AM, Majoni SW, Falhammar H. Magnesium and human health: perspectives and research directions. Int J Endocrinol. 2018, 2018:9041694. 10.1155\/2018\/9041694","journal-title":"Int J Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-013-0012-x","article-title":"Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics","volume":"15","author":"Ward RM","year":"2013","unstructured":"Ward RM, Kearns GL. Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs. 2013, 15:119-31. 10.1007\/s40272-013-0012-x","journal-title":"Paediatr Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200305010-00003","article-title":"The use of proton pump inhibitors in children: a comprehensive review","volume":"5","author":"Gibbons TE","year":"2003","unstructured":"Gibbons TE, Gold BD. The use of proton pump inhibitors in children: a comprehensive review. Paediatr Drugs. 2003, 5:25-40. 10.2165\/00128072-200305010-00003","journal-title":"Paediatr Drugs"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/00912700222011562","article-title":"Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study","volume":"42","author":"Metz DC","year":"2002","unstructured":"Metz DC, Ferron GM, Paul J, Turner MB, Soffer E, Pisegna JR, Bochenek WJ. Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study. J Clin Pharmacol. 2002, 42:512-9. 10.1177\/00912700222011562","journal-title":"J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1021\/ja049607w","article-title":"Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors","volume":"126","author":"Shin JM","year":"2004","unstructured":"Shin JM, Cho YM, Sachs G. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J Am Chem Soc. 2004, 126:7800-11. 10.1021\/ja049607w","journal-title":"J Am Chem Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2013.19.1.25","article-title":"Pharmacokinetics and pharmacodynamics of the proton pump inhibitors","volume":"19","author":"Shin JM","year":"2013","unstructured":"Shin JM, Kim N. Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. J Neurogastroenterol Motil. 2013, 19:25-35. 10.5056\/jnm.2013.19.1.25","journal-title":"J Neurogastroenterol Motil"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13846","article-title":"Mechanisms of proton pump inhibitor-induced hypomagnesemia","volume":"235","author":"Gommers LM","year":"2022","unstructured":"Gommers LM, Hoenderop JG, de Baaij JH. Mechanisms of proton pump inhibitor-induced hypomagnesemia. Acta Physiol (Oxf). 2022, 235:e13846. 10.1111\/apha.13846","journal-title":"Acta Physiol (Oxf)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v5.i2.152","article-title":"Proton-pump inhibitor-induced hypomagnesemia: current research and proposed mechanisms","volume":"5","author":"William JH","year":"2016","unstructured":"William JH, Danziger J. Proton-pump inhibitor-induced hypomagnesemia: current research and proposed mechanisms. World J Nephrol. 2016, 5:152-7. 10.5527\/wjn.v5.i2.152","journal-title":"World J Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000259","article-title":"Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study","volume":"27","author":"Hess MW","year":"2017","unstructured":"Hess MW, de Baaij JH, Broekman MM, et al.. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study. Pharmacogenet Genomics. 2017, 27:83-8. 10.1097\/FPC.0000000000000259","journal-title":"Pharmacogenet Genomics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0149-2918(95)80110-3","article-title":"Effect of omeprazole on changes in gastric and upper small intestine pH levels in patients with chronic pancreatitis","volume":"17","author":"Nakamura T","year":"1995","unstructured":"Nakamura T, Arai Y, Tando Y, et al.. Effect of omeprazole on changes in gastric and upper small intestine pH levels in patients with chronic pancreatitis. Clin Ther. 1995, 17:448-59. 10.1016\/0149-2918(95)80110-3","journal-title":"Clin Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05201.x","article-title":"Systematic review: hypomagnesaemia induced by proton pump inhibition","volume":"36","author":"Hess MW","year":"2012","unstructured":"Hess MW, Hoenderop JG, Bindels RJ, Drenth JP. Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther. 2012, 36:405-13. 10.1111\/j.1365-2036.2012.05201.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.43688","article-title":"Serum magnesium in recovering acute renal failure","volume":"18","author":"Satish R","year":"2008","unstructured":"Satish R, Gokulnath G. Serum magnesium in recovering acute renal failure. Indian J Nephrol. 2008, 18:101-4. 10.4103\/0971-4065.43688","journal-title":"Indian J Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24134","article-title":"Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia","volume":"115","author":"Nijenhuis T","year":"2005","unstructured":"Nijenhuis T, Vallon V, van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005, 115:1651-8. 10.1172\/JCI24134","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.13251","article-title":"How much magnesium sulfate is needed to \"keep total serum magnesium above 2.0\u2009mg\/dL\"?","volume":"19","author":"Kwon J","year":"2024","unstructured":"Kwon J, Lucas BP, Evans AT. How much magnesium sulfate is needed to \"keep total serum magnesium above 2.0\u2009mg\/dL\"?. J Hosp Med. 2024, 19:112-5. 10.1002\/jhm.13251","journal-title":"J Hosp Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/229837-a-case-of-severe-proton-pump-inhibitor-induced-hypomagnesemia-refractory-to-continuous-oral-and-intravenous-magnesium-replenishment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:11:28Z","timestamp":1708387888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/229837-a-case-of-severe-proton-pump-inhibitor-induced-hypomagnesemia-refractory-to-continuous-oral-and-intravenous-magnesium-replenishment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.54483","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,19]]}}}